Hot Features
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 d... Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.22 | 10.2325581395 | 2.15 | 2.4699 | 2.06 | 6813 | 2.09012828 | CS |
| 4 | -0.58 | -19.6610169492 | 2.95 | 3.0396 | 1.92 | 15613 | 2.27828733 | CS |
| 12 | -0.63 | -21 | 3 | 3.14 | 1.92 | 15120 | 2.57744118 | CS |
| 26 | -0.89 | -27.3006134969 | 3.26 | 4.04 | 1.92 | 18026 | 2.87928248 | CS |
| 52 | -2.67 | -52.9761904762 | 5.04 | 6.2 | 1.67 | 154513 | 3.43874352 | CS |
| 156 | 1.94 | 451.162790698 | 0.43 | 6.2 | 0.044 | 918090 | 0.45743066 | CS |
| 260 | 1.504 | 173.672055427 | 0.866 | 6.2 | 0.044 | 1304328 | 0.86450285 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.